First to gain major laser eye surgery accreditation

Article

Ultralase has become the first and only national provider to have all its UK surgeons accredited by the Royal College of Ophthalmologists (RCOphth).

Ultralase has become the first and only national provider to have all its UK surgeons accredited by the Royal College of Ophthalmologists (RCOphth).

All refractive surgeons practising across Ultralase’s network of over 25 British clinics received the RCOphth 'Certificate in Laser Refractive Surgery' after undergoing strict assessments in areas such as surgical skills and patient management.

Research from a survey conducted by Optician magazine and the British Society for Refractive Surgery (September/October 2008) revealed that the experience of a surgeon is the number one factor people consider when choosing a clinic.

Kathy Evans, chief executive for the RCOphth, added: “The assessment was set up for the benefit of patients and we are delighted that the number of surgeons now obtaining the certificate has increased.”

Mark Korolkiewicz, clinical services director at Ultralase, said: “For our refractive surgeons to be certified by the RCOphth is testament to the high levels of skill, knowledge and expertise we can offer to patients.”

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.